191
Evaluation Of Acceptability And Satisfaction Of Hemophilia Patients Treated With FusENGO
Condition(s):Hemophilia ALast Updated:September 25, 2018Completed
Factor VIII: 922 Clinical Trials, Page 20 of 93
Hide Studies Not Open or Pending
192
Phenotypic Heterogeneity in Hemophilia A: An Investigation of the Role of Platelet Function
Condition(s):Hemophilia ALast Updated:February 3, 2017Completed
193
Safety and Efficacy Study of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Hemophilia A Patients Undergoing Surgery
Condition(s):Hemophilia ALast Updated:August 24, 2021Completed
194
Evaluation of Patient and Physician Reported Reasons for Switching Factor VIII Replacement Therapies
Condition(s):Hemophilia ALast Updated:September 27, 2018Completed
195
Prospective Biomarkers of Bone Metabolism in Hemophilia A
Condition(s):Hemophilia; Bone DiseaseLast Updated:April 1, 2020Completed
196
Safety, Efficacy and Pharmacokinetics of GreenGene™ F to Previously Treated Patients With Severe Hemophilia A
Condition(s):Hemophilia ALast Updated:July 3, 2014Unknown status
197
A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Subcutaneous Emicizumab in Participants From Birth to 12 Months of Age With Hemophilia A Without Inhibitors
Condition(s):Severe Hemophilia ALast Updated:August 22, 2023Active, not recruiting
198
A Study Evaluating Physical Activity and Joint Health in Severe Haemophilia A Patients ≥12 Years Treated Once Weekly With Efanesoctocog Alfa
Condition(s):Hemophilia A, SevereLast Updated:September 5, 2023Recruiting
199
A Multinational, Open-Label, Non-Controlled Trial on Safety, Efficacy and Pharmacokinetics of NNC 0129-0000-1003 in Previously Treated Paediatric Patients With Severe Haemophilia A
Condition(s):Congenital Bleeding Disorder; Haemophilia ALast Updated:November 23, 2020Completed
200
Treatment of Hemophilia A Patients With FVIII Inhibitors
Condition(s):Hemophilia ALast Updated:August 14, 2023Recruiting